Wellington Management Group’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $68.1M | Sell |
2,174,761
-1,614,436
| -43% | -$50.5M | 0.01% | 618 |
|
|
2025
Q1 | $127M | Buy |
3,789,197
+11,586
| +0.3% | +$389K | 0.02% | 454 |
|
|
2024
Q4 | $148M | Sell |
3,777,611
-65,836
| -2% | -$2.58M | 0.03% | 441 |
|
|
2024
Q3 | $151M | Buy |
3,843,447
+15,226
| +0.4% | +$599K | 0.03% | 445 |
|
|
2024
Q2 | $149M | Sell |
3,828,221
-93,837
| -2% | -$3.66M | 0.03% | 449 |
|
|
2024
Q1 | $169M | Sell |
3,922,058
-240,596
| -6% | -$10.4M | 0.03% | 424 |
|
|
2023
Q4 | $192M | Buy |
4,162,654
+2,434,546
| +141% | +$112M | 0.04% | 407 |
|
|
2023
Q3 | $59M | Buy |
1,728,108
+677,057
| +64% | +$23.1M | 0.01% | 651 |
|
|
2023
Q2 | $40.5M | Buy |
1,051,051
+803,614
| +325% | +$30.9M | 0.01% | 765 |
|
|
2023
Q1 | $8.86M | Buy |
+247,437
| New | +$8.86M | ﹤0.01% | 1136 |
|